Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.
Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.
Topics: Most Viewed, Rob Laurens, Aaron Fleishman, Elizabeth Gargill, Crystal Ball, Michael Turner, 2023 Predictions, Andre Briola, Erica Mercado
According to the Centers for Disease Control and Prevention (CDC), among the top ten leading causes of death in the United States per year are diseases that include heart disease (696,962), cancer (602,350), stroke (160,264), Alzheimer’s disease (134,242) and diabetes (102,188).1 It makes sense, then, that there would be substantial clinical efforts to provide preventative and curative treatments for these conditions. However, when planning your trial to test the efficacy of your treatment, how often do you reflect on the actual patient population?
Topics: Most Viewed, DEI, Michael Turner, Diversity, Equity, Inclusion